Crossmark

Obesity Pharmacotherapy: a Review of Current Practices and Future Directions

Published Online: 2023-02-08

Authors

Schmitz, Sarah https://orcid.org/0000-0002-4993-8978
Tchang, Beverly G.

Shukla, Alpana P.
License Information

Text and Data Mining valid from 2023-02-08

Version of Record valid from 2023-02-08
More Information

Article History

Accepted: 23 December 2022

First Online: 8 February 2023

Compliance with Ethical Standards

:

: Sarah Schmitz does not have existing conflicts of interest.Beverly G. Tchang receives consulting fees from Novo Nordisk and Gelesis.Alpana P. Shukla receives research funding from Novo Nordisk.

Document is current